KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

20 hedge funds and large institutions have $91.5M invested in Kindred Biosciences, Inc. in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
20
Holders Change
+20
Holders Change %
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BG
1
Baupost Group
Massachusetts
$32.4M 2,900,000 +2,900,000 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$14.8M 1,321,372 +1,321,372 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$12.3M 1,100,000 +1,100,000 New
Jennison Associates
4
Jennison Associates
New York
$10M 901,774 +901,774 New
KCM
5
Kingdon Capital Management
New York
$6.68M 600,000 +600,000 New
Franklin Resources
6
Franklin Resources
California
$3.37M 302,800 +302,800 New
DM
7
Deerfield Management
New York
$2.51M 225,000 +225,000 New
AWMDMG
8
Austin W. Marxe & David M. Greenhouse
New York
$2.23M 200,000 +200,000 New
PI
9
Putnam Investments
Massachusetts
$1.67M 150,000 +150,000 New
TG
10
TCW Group
California
$1.61M 144,699 +144,699 New
DCM
11
Driehaus Capital Management
Illinois
$1.58M 141,519 +141,519 New
FCM
12
Farallon Capital Management
California
$918K 82,445 +82,445 New
BI
13
BVF Inc
California
$577K 51,788 +51,788 New
HVC
14
Healthcare Value Capital
New Jersey
$559K 50,000 +50,000 New
HHC
15
Hutchin Hill Capital
New York
$131K 11,719 +11,719 New
CCA
16
Catalyst Capital Advisors
New York
$111K 10,000 +10,000 New
TRCT
17
Tower Research Capital (TRC)
New York
$55K 4,918 +4,918 New
U
18
UBS
Switzerland
$14K 1,291 +1,291 New
Morgan Stanley
19
Morgan Stanley
New York
$6K 500 +500 New
Citigroup
20
Citigroup
New York
$1K 84 +84 New